Photo credit: www.technologyreview.com
DOGE’s Initiative to Tackle Waste in Government Spending
The current administration has announced that the primary objective of DOGE’s operations is to significantly reduce waste, fraud, and abuse, according to a spokesperson’s remarks to the New York Times.
As highlighted in a recent article, the definitions of these terms vary considerably within the context of federal budgeting. Waste can stem from genuine errors in government spending, while fraud may encompass legal expenditures that are nonetheless viewed as inappropriate or unnecessary by certain authorities.
Numerous bold measures undertaken by the new administration, including Elon Musk’s commitment to eliminate the entirety of USAID’s activities and former President Trump’s drastic reductions to the National Institutes of Health funding, appear to primarily address the latter category of spending. If DOGE integrates government data into advanced language models, it could efficiently identify expenditures related to diversity, equity, and inclusion (DEI) initiatives or other areas that the current leadership deems superfluous in light of the proposed $2 trillion budget cuts, which would amount to nearly one-third of the federal budget.
However, reports suggest that DOGE team members are now operating within the realms of Medicaid and Medicare, sectors where budget reductions have faced substantial political resistance over the years. This involvement may be informed by findings from the Government Accountability Office (GAO). The GAO’s insights provide a glimpse into what DOGE aims to achieve through the integration of artificial intelligence.
According to GAO reports, six federal programs are responsible for approximately 85% of the erroneous payments — translating to around $200 billion annually — with Medicare and Medicaid at the top of this list. While these programs constitute a minor portion of total federal expenditures, they account for nearly 14% of the federal deficit. Estimates of fraudulent activity, where individuals are legally found to have intentionally misrepresented facts for financial gain, range from $233 billion to $521 billion every year.
This brings into question the specific areas where fraud is prevalent and whether AI technologies could offer solutions, as anticipated by the DOGE initiative. To explore these concerns, I engaged with Jetson Leder-Luis, an economist at Boston University, who specializes in analyzing fraudulent federal payments in health care and the potential role of algorithms in mitigating these issues.
Leder-Luis highlights that a significant portion of healthcare fraud, in terms of financial impact, is perpetrated by pharmaceutical companies. Often, these companies market drugs for purposes that have not received official approval, a practice known as “off-label promotion,” which constitutes fraud when reimbursed by Medicare or Medicaid. Other fraudulent behaviors can include “upcoding,” where a provider bills for a higher-cost service than what was rendered, as well as medical-necessity fraud, where patients receive unneeded or unauthorized services. Additionally, some companies provide inadequate services while still receiving payment.
Source
www.technologyreview.com